The antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterised by the persistent presence of antiphospholipid antibodies (aPL) and clinical features of thrombosis and/or pregnancy morbidity (1). This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.